Company / Capital Expenditures
Avanos Medical, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$31.6M
FY2025
5-year range
$17.8M / $31.6M
FY2021-FY2025
Trend
+77.5%
vs FY2024
Sector context
#90 of 145
Health Care
What the data says
At $32M, Avanos Medical, Inc.'s capital expenditures ranks #90 of 145 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $18M in FY2024 to $51M in FY2019.
Based on SEC 10-K filings.
$32M in FY2025 with a 5-year CAGR of +9.4%.
Improved from $18M to $32M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
#90 of 145 in Health CareTop 62% of 145This company $31.6M Sector average $268.6M
▼
-88.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.4%, indicating consistent growth.
- In FY2025, capital expenditures increased 77.5% year-over-year.
- Ranks #90 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.6M | +77.5% |
| FY2024 | $17.8M | +0.0% |
| FY2023 | $17.8M | -7.8% |
| FY2022 | $19.3M | -8.1% |
| FY2021 | $21.0M | +4.0% |
| FY2020 | $20.2M | -60.1% |
| FY2019 | $50.6M | +3.1% |
| FY2018 | $49.1M | +13.7% |
| FY2017 | $43.2M | +48.5% |
| FY2016 | $29.1M | -58.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026